Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR

This study aimed to investigate real-world evidence for efficacy and safety of durvalumab consolidation (DC) after chemoradiotherapy (CRT) in patients with unresectable stage III NSCLC. Patients with stage III NSCLC who started DC after CRT between September 2018 and December 2020 and were treated a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thoracic oncology 2023-08, Vol.18 (8), p.1042-1054
Hauptverfasser:	Park, Cheol-Kyu, Oh, Hyung-Joo, Kim, Young-Chul, Kim, Yong-Hyub, Ahn, Sung-Ja, Jeong, Won Gi, Lee, Jeong Yeop, Lee, Jae Cheol, Choi, Chang Min, Ji, Wonjun, Song, Si Yeol, Choi, Juwhan, Lee, Sung Yong, Kim, Hakyoung, Lee, Shin Yup, Park, Jongmoo, Yoon, Seong Hoon, Joo, Ji Hyeon, Oh, In-Jae
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemoradiotherapy Durvalumab Non–small cell lung cancer Real-world data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!